Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amiloride and furosemide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide and potassium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only furosemide and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only furosemide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride and furosemide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only furosemide and spironolactone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only furosemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Furosemide 20 mg and spironolactone 50 mg oral capsule |
Has precise active ingredient |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely furosemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely furosemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride anhydrous (as amiloride hydrochloride) 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride anhydrous (as amiloride hydrochloride) 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Furosemide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |